Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERTICOEUR: Everolimus vs CNI for Skin Cancer Prevention in Heart Transplant
NCT00799188Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2008
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in skin cancer, sponsored by Hospices Civils de Lyon. Started Oct 2008; status: completed.
02
Drugs
everolimus
03
Conditions
skin cancer
Beyond the preview
Go deeper on NCT00799188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799188.